QA: Clearside Biomedical Inc in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001539029_2021_Clearside_Biomedical_Inc.pdf

Logs

warning Similarly named company. Duplicate? None {'details': [{'other_company': 'Lifecore Biomedical INC DE', 'shared_tokens': {'biomedical'}}]}

Graph

Absolute values for 0001539029, Clearside Biomedical Inc

  xvar xval
0 AssetsCurrent 18,118,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 416,000
3 remainder_Assets 788,000
4 LiabilitiesCurrent 9,943,000
5 LiabilitiesNoncurrent 616,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,850,451
9 ResearchAndDevelopmentExpense 15,050,396
10 remainder_Expenses 0
11 remainder_Revenues 36,481,733
12 remainder_NetIncome -360,005
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 19,322,000
1 Liabilities 10,559,000
2 Expenses 20,900,847
3 Revenues 36,481,733
4 StockholdersEquity 8,763,000
5 NetIncome 15,220,881
6 ComprehensiveNetIncome 15,220,881
7 BaseVar 43,811,792
8 EconomicCapitalRatiobeforeLimitedLiability 2.30
9 EconomicCapitalRatio 3.22

Edgar->Model Mapping

Feature Distribution

Change over Time